IL6 and head and neck squamous cell carcinoma: Similarly, IL-6 secreted by HNSCC cells initiates the STAT3 signaling pathway, thereby reducing NK cell activity and function, and enhancing HNSCC malignancy in conjunction with IL-8 (72).